Alteration in cardiac biomarkers associated with breast cancer therapy-induced cardiotoxicity
Zanco Journal of Medical Sciences · 10.05.2026 · 30 (1) · 201-212
DOI: 10.15218/zjms.2026.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zanco Journal of Medical Sciences, online erschienen am 23.04.2026. Verfasst von Barzy Hassan und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background and objective: Breast cancer medications, including chemotherapy, radiation, and targeted treatments, are linked to increased cardiovascular risk, frequently leading to early cardiac dysfunction. This study examines cardiac and lipid biomarker alterations throughout breast cancer chemotherapy and their correlation with cardiovascular problems.
Methods
A case-control study involved 90 females, 60 breast cancer patients (30 before and 30 after treatment), and 30 healthy controls. Serum levels of lipid profile (Total Cholesterol, Triglycerides, HDL-C, LDL-C, VLDL-C), the tumor marker CA 15-3, and cardiac biomarkers Brain Natriuretic Peptide (BNP), Troponin T, CK-MB, Gamma-Glutamyl Transferase (GGT), and C-reactive Protein (CRP) were assessed.
Results
The mean age was 44±1.64 for the controls and 46.53±1.14 in patients. The BMI was significantly higher in breast cancer patients (P
Zitieren
APA
Hassan, B., & Ahmed, S. (2026). Alteration in cardiac biomarkers associated with breast cancer therapy-induced cardiotoxicity. Zanco Journal of Medical Sciences, 30(1), 201-212. https://doi.org/10.15218/zjms.2026.015
Vancouver
Hassan B, Ahmed S. Alteration in cardiac biomarkers associated with breast cancer therapy-induced cardiotoxicity. Zanco Journal of Medical Sciences. 2026;30(1):201-212. doi:10.15218/zjms.2026.015
BibTeX
@article{Hassan2026,
author = {Hassan, Barzy and Ahmed, Sardar},
title = {Alteration in cardiac biomarkers associated with breast cancer therapy-induced cardiotoxicity},
journal = {Zanco Journal of Medical Sciences},
year = {2026},
volume = {30},
number = {1},
pages = {201--212},
doi = {10.15218/zjms.2026.015}
}
EUVIMED